Park K - Search Results

1

A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.

Park J, Ahn YC, Kim H, Lee SH, Park SH, Lee KE, Lim DH, Park J, Kim K, Jung CW, Im YH, Kang WK, Lee MH, Park K. Park J, et al. Among authors: park sh, park k. Lung Cancer. 2003 Nov;42(2):227-35. doi: 10.1016/s0169-5002(03)00282-4. Lung Cancer. 2003. PMID: 14568691 Clinical Trial.

2

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer.

Wu HG, Bang YJ, Choi EK, Ahn YC, Kim YW, Lim TH, Suh C, Park K, Park CI. Wu HG, et al. Among authors: park ci, park k. Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):75-80. doi: 10.1016/s0360-3016(01)01739-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 11777624 Clinical Trial.

3

Sexuality and quality of life after hematopoietic stem cell transplantation.

Lee HG, Park EY, Kim HM, Kim K, Kim WS, Yoon SS, Kang WK, Park KC, Park CH. Lee HG, et al. Among authors: park kc, park ch, park ey. Korean J Intern Med. 2002 Mar;17(1):19-23. doi: 10.3904/kjim.2002.17.1.19. Korean J Intern Med. 2002. PMID: 12014208 Free PMC article.

4

Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.

Kim K, Nam E, Lee NS, Lee HR, Lee JY, Lee HR, Park SH, Oh SY, Kim JH, Song SY, Park JO, Kim WS, Jung CW, Im YH, Lee MH, Lee WY, Chun H, Park CH, Park K, Kang WK. Kim K, et al. Among authors: park sh, park jo, park ch, park k. Am J Clin Oncol. 2002 Aug;25(4):354-7. doi: 10.1097/00000421-200208000-00007. Am J Clin Oncol. 2002. PMID: 12151964 Clinical Trial.

5

Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.

Kim K, Lee MH, Kim J, Lee KS, Kim SM, Jung MP, Han J, Sung KW, Kim WS, Jung CW, Yoon SS, Im YH, Kang WK, Park K, Park CH. Kim K, et al. Among authors: park ch, park k. Am J Hematol. 2002 Oct;71(2):75-9. doi: 10.1002/ajh.10168. Am J Hematol. 2002. PMID: 12353303 Free article.

6

Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesis.

Park C, Kim WS, Choi Y, Kim H, Park K. Park C, et al. Among authors: park k. Lung Cancer. 2002 Nov;38(2):143-7. doi: 10.1016/s0169-5002(02)00182-4. Lung Cancer. 2002. PMID: 12399125

7

Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis.

Hyun Park W, Hee Cho Y, Won Jung C, Oh Park J, Kim K, Hyuck Im Y, Lee MH, Ki Kang W, Park K. Hyun Park W, et al. Among authors: park k. Biochem Biophys Res Commun. 2003 Jan 3;300(1):230-5. doi: 10.1016/s0006-291x(02)02831-0. Biochem Biophys Res Commun. 2003. PMID: 12480548

8

Aggressive natural killer cell leukemia: clinical features and treatment outcome.

Song SY, Kim WS, Ko YH, Kim K, Lee MH, Park K. Song SY, et al. Among authors: park k. Haematologica. 2002 Dec;87(12):1343-5. Haematologica. 2002. PMID: 12495907 No abstract available.

9

Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis.

Park WH, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK, Park K. Park WH, et al. Among authors: park jo, park k. Int J Oncol. 2003 Apr;22(4):855-60. Int J Oncol. 2003. PMID: 12632079

10

Adenocarcinoma of unknown primary site.

Song SY, Kim WS, Lee HR, Jung HS, Oh SY, Kim JH, Kim K, Nam EM, Oh YR, Jung CW, Yoon SS, Im YH, Lee HG, Kang WK, Park CH, Park K. Song SY, et al. Among authors: park ch, park k. Korean J Intern Med. 2002 Dec;17(4):234-9. doi: 10.3904/kjim.2002.17.4.234. Korean J Intern Med. 2002. PMID: 12647637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,315 results

Search Page

Filters